It’s a real ray of hope for patients suffering form dreaded disease like ALS or Lou ALSGehrig’s diseases. ALS is one of the most common neuromuscular diseases world wide. Famous suffering personalities like Stephen Hawking, guitarist Jason Becker and baseballer Lou Gehrig brought the disease to spot light.

Amyotrophic lateral sclerosis (ALS), often referred to as “Lou Gehrig’s Disease,” is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. As motor neurons degenerate, they can no longer send impulses to the muscle fibers that normally result in muscle movement.

Approximately 5,600 people in the U.S. are diagnosed with ALS each year. The incidence of ALS is two per 100,000 people, and it is estimated that as many as 30,000 Americans may have the disease at any given time.

Presently there is no such treatment to control ALS except FDA approved Riluzole, which could slow the progress to some extent.

Now at last it is found that autologous stem cell therapy can effectively improve the condition of patients who are suffering from amyotrophic lateral sclerosis, or Lou Gehrig’s disease.

A recent follow up study in Thailand which was arranged by Asian health care provider Returning Hope has proved and effectively shows some rays of hope against this untreatable ALS.

The follow up study was conducted by a team from Akay Hospital, GATA, the University of Marmara, and the Sila Neurorehabilitation Center. It followed 13 patients for one year after stem cell treatment for ALS.

Summary of the study results of 13 ALS patients:

  • According to the result of electroneuromyography, nine out of thirteen patients shown significant improvements.
  • One patient’s condition was stable, with no improvement or decline.
  • Three patients died from conditions unrelated to ALS, including lung infection and myocardial infarction.

Brian Dardzinski, Returning Hope’s CEO, who was very much optimistic about the result of the trial is highly pleased with the successful outcome that proves the efficacy of stem cell treatment against ALS and also hopes that the success of the new study will encourage more patients to go for the treatment.

Returning Hope is an online portal and facilitator, providing information and assistance to patients looking for adult stem cell treatment. Most of the procedures that Returning Hope facilitates involve autologous transplants - stem cells are harvested from a patient’s own fat in a quick, simple bedside procedure and re-implanted.

For further information:
You may contact Brain Dardzinski, CEO at-  bdardzinski ( @ ) returninghope dot com

Web :

Source: 1888 PressRelease